Strykervs.Zimmer Biomet
SYK vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Stryker is about 6.0× larger than Zimmer Biomet by market cap; Zimmer Biomet trades at the lower P/E (21.5 vs 28.0); year to date, Zimmer Biomet leads (−1.6% vs −21.6%).
Side by side
| SYK | ZBH | |
|---|---|---|
| Market cap | $105B | $17.3B |
| Price | $276.97 | $88.88 |
| Today | +0.6% | +0.4% |
| Return YTD | −21.6% | −1.6% |
| Return 1Y | −25.4% | −10.7% |
| Since June 26, 2026 | −16.8% | −4.5% |
| P/E | 28.0 | 21.5 |
| P/S | 4.0 | 2.0 |
| P/B | 4.4 | 1.4 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
StrykerSYK
Orthopaedic implants and surgical equipment, with Mako bringing robot assistance into the operating room.
Full SYK profile →More SYK & ZBH comparisons
Other head-to-heads in the Medtech & devices segment.
See where SYK and ZBH sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →